Republican "divisions" in opinion on a bipartisan drug pricing bill have slowed further action on the legislation so far, Senate Majority Leader Mitch McConnell, R-Ky., said, according to The Hill.
Mr. McConnell was referring to a bill sponsored by Sens. Chuck Grassley, R-Iowa, and Ron Wyden, D-Ore., that caps annual out-of-pocket drug costs for Medicare patients and requires pharmaceutical companies to include list prices in advertisements, among other provisions. The hang-up for some Senate Republicans revolves around a provision in the bill that ties Medicare drug price increases to the inflation rate, according to The Hill.
During his State of the Union address earlier this month President Donald Trump indicated he would approve the bill if the Senate can work out its differences. "Get a bill on my desk, and I will sign it into law without delay," he said.
Read the full story from The Hill here.
More articles on leadership and management:
10 hospitals hiring CEOs
One Brooklyn Health System appoints first chairpersons
7 healthcare sound bites from Friday's Democratic debate